Lymphogranuloma Venereum 'At A Glance: Epidemiology
Lymphogranuloma Venereum 'At A Glance: Epidemiology
Lymphogranuloma Venereum 'At A Glance: Epidemiology
Endemic in Africa, Southeast Asia, and South and Diagnosis by identification of organism and by
Central America, and rare in developed countries. serology or genotyping.
Recent outbreaks among men who have sex with Doxycycline or erythromycin treatment curative if
men in Europe and North America. given early.
EPIDEMIOLOGY
Lymphogranuloma venereum (LGV) is a sexually
transmitted disease due to specific Chlamydia vari- ants
that is rare in developed countries. It is endemic in
East and West Africa, India, Southeast Asia, South and
Central America, and some Caribbean Islands; and
2506 accounts for 7%–19% of genital ulcer diseases in areas
1,2
of Africa and India. The peak incidence occurs in
persons 15–40 years of age, in urban areas, and in
individuals of lower socioeconomic status. Men are six
times more likely than women to manifest clinical
3
infection. The incidence of LGV is low in the devel-
oped world where cases are usually limited to trav-
elers or military personnel returning from endemic
Se areas. Since 2003, however, outbreaks of LGV have
cti appeared in Europe, Australia, and North America,
on particularly in the form of proctitis, among human
32 immunodeficiency virus (HIV) positive men who have
4–11
:: sex with men (MSM).
Se LGV is contracted by direct contact with infectious
xu secretions, usually through any type of unprotected
all intercourse, whether oral, vaginal, or anal. Trans-
12,13
y mission efficiency is unknown. Sexual practices
such as fisting and sex-toy sharing may be other
Tr 4
routes of transmission. In a recent study that com-
an pared sexual behaviors in men with LGV and men
sm with non-LGV chlamydial proctitis, fisting was a
itt 14
major predisposing factor. An epidemic of LGV
ed has been reported among “crack” cocaine users in
15
Di the Bahamas.
se Due to underdiagnosis and underreporting, the
as epidemiology of LGV remains poorly understood.
es Common diagnostic laboratory methods are non-
specific and not readily available in endemic areas.
Even in industrialized countries, only a few labora-
tories offer specific assays to LGV serovars. Without
such assays, many LGV cases are misdiagnosed as
common chlamydial urogenital infection. Underdi-
agnosis of LGV is also largely due to the presence of
an asymptomatic carrier state. Women, in particu- lar,
may harbor asymptomatic persistent infection in
the cervical epithelium, thus serving as reservoirs of
the infection as they do for other urogenital chla-
mydial infections and gonorrhea. Recently, a large
study conducted in the United Kingdom found
that only 6% of MSM were asymptomatic carriers
of LGV Chlamydia serovars; the majority of cases of
16
LGV in the rectum and urethra were symptomatic.
Infectivity in men usually ceases after healing of the
primary mucosal lesion. Interestingly, most of the
detected cases in the recent outbreaks are in men who
practice receptive anal sex, suggesting that a high
proportion of men who practice insertive anal sex are
mis- or scarlatiniform exanthema may occur with any of these
21
undiagno stages.
sed. The
reasons ETIOLOGY AND PRiMARy STAgE. Three to 30 days after infection,
behind PATHOGENESIS 5- to 8-mm painless erythematous papule(s) or small
this are herpetiform ulcers appear at the site of inoculation
22
unclear (Fig. 203-1). Painful ulcerations and nonspecific ure-
LGV (tropical or climatic bubo, lymphopathia 23
but may thritis are less common. In males, the lesion is
venerea, Nicolas–Favre disease) is caused by
be usually
Chlamydia tracho- matis serovars (serologic variants)
organism 17 found on the coronal sulcus, prepuce, or glans penis;
L1, L2, and L3.
-related, and in females on the posterior wall of the vagina,
Most of the recent outbreaks are caused by a
host- vulva, or, occasionally, the cervix. Inoculation may
number of strains of C. trachomatis L2 serovar (L2b),
related also
suggesting that these outbreaks most likely represent
(sexual 7– be rectal or pharyngeal. The primary lesion is
increased awareness of a slowly evolving endemic.
practices 9,16,18,19 transient,
such as often heals within a few days, and may go unnoticed.
Chlamydiae are obligate intracellular bacteria charac-
fisting
terized by two distinct morphologic forms: (1) the SECoNDARy STAgE. A few weeks after the pri-
and the
small metabolically inactive and infectious elementary
use of mary lesion appears, marked LN involvement and
body, and (2) the larger metabolically active and
sex toys, hematogenous dissemination occur, manifested by
noninfectious reticulate body. (eFig. 203-0.1 in online
intraveno variable signs and symptoms, including fever, myal-
edition). C. tracho- matis has been subdivided into
us drug gia, decreased appetite, and vomiting. Photosensi-
several serovars that dif- fer in their major outer
use, HIV tivity may develop in up to 35% of the cases, often
membrane proteins, and which are associated with
status, 24
several diseases. Serovars A, B, and C are the causes 1–2 months after bubo formation. Less commonly,
etc.) or
of trachoma ocular infections, whereas serovars D-K patients may develop meningoencephalitis, hepato-
physician
are responsible for ocular, genital and respi- ratory splenomegaly, arthralgia, and iritis.
25,26
The lymphad-
-related 20
infections. In contrast to the A-K serovars that enitis episodes often resolve spontaneously in 8–12
(failure
remain confined to the mucosa, LGV serovars are weeks. Depending on the mode of transmission, two
to
more invasive and have a high affinity for major syndromes are distinguished.
diagnose 17
macrophages. After being inoculated onto the
genital
mucosal surface, the organisms replicate within
LGV).
macrophages, and find their way to the draining
The
lymph nodes (LNs), and cause lymphadenitis.
resurgenc
e of LGV
as a
health
CLINICAL
problem FINDINGS
may
simply
reflect CUTANEOUS LESIONS AND
increased RELATED PHYSICAL FINDINGS
awarenes
s rather Clinical manifestations are protean, depending on
than the sex of the patient, acquisition mode, and the
increased disease stage. Three clinical stages characterize LGV.
incidence Nonspe- cific cutaneous lesions such as erythema
. nodosum, erythema multiforme, urticaria, and
32
Ch
Figure 203-3 Lymphogranuloma venereum: bilateral, apt
firm, immovable masses above Poupart’s ligament.
er
20
which may rupture and drain through the skin,
form- ing sinus tracts. Bilateral involvement occurs 3
in one- third of the cases (Fig. 203-3). Nodal ::
enlargement on either side of the inguinal ligament, Ly
the “groove sign,” is pathognomonic of LGV, but m
Figure 203-1 Lymphogranuloma venereum: soft painless 27
only presents in 10%–20% of cases and is rarely ph
erosion on the prepuce. 28
bilateral. In women, inguinal lymphadenitis is og
unusual because the lymphatic drainage of the ra
The acute genital syndrome (GS) or inguinal syn- vagina and cervix is to the deep nu
drome is characterized by inguinal and/or femoral pelvic/retroperitoneal LN. When these nodes are lo
LN involvement and is the major presentation in involved, low abdominal/back pain that exacerbates
m
men. Initially, the skin overlying the affected LN is upon lying supine and pelvic adhesions may ensue.
The acute anorectal syndrome (ArS) is character- a
erythematous and indurated. Over the subsequent Ve
1–2 weeks, the LN enlarge and coalesce to form a ized by perirectal nodal involvement, acute hemor-
rhagic proctitis, and pronounced systemic ne
firm and tender immovable mass (bubo) (Fig. 203-2),
symptoms. It is the most common presentation in re
women and in homosexual men who practice anal u
sex. The major source of rectal spread in women is
the internal lym- phatic drainage of the lower two-
thirds of the vagina. Patients may complain of anal
pruritus, bloody rec- tal discharge, tenesmus,
5,29
diarrhea, constipation, and lower abdominal pain.
In a recent study, 96% of MSM patients presented
30
with signs and symptoms of proctitis. Despite
affecting mostly HIV-positive MSM, LGV has not
behaved as an opportunistic infection in the recent
outbreak, and clinical features have not differed
31
between HIV-positive and HIV- negative cases.
32
an
sm
itt
ed OTHER UNUSUAL MANIFESTATIONS
is rare. Oropha- ryngeal infection
may manifest initially as pinhead-
sized vesicles on the lip, and later on
as cervical lymphadenopathy with
Di constitutional symptoms, closely
se mimicking lymphoma. Tonsillitis,
as
supracla- vicular and mediastinal lymphadenopathy,
34–38
and peri- carditis rarely occur. Ocular
autoinoculation of infected discharges may lead to microimmunofluorescence test for the L-type serovar
conjunctivitis with marginal corneal perforation, often is more sensitive & specific but less readily available.
47
39
with preauricular lymphadenopathy. Inhalation of In addition, culture studies may be preformed; how-
LGV serovars L1 and L2 may accidentally occur in ever, they do not distinguish between LGV and non-
laboratory workers and lead to pneumonitis with LGV serovars, are tedious, and require special growth
40
mediastinal and supra- clavicular lymphadenopathy. media. Nevertheless, a positive culture without cen-
trifugation is highly suggestive of LGV.
In addition, direct fluorescence microscopy using
LABORATORY TESTS conjugated monoclonal antibody against C.
trachomatis on smears from bubo material or genital
48
Diagnosis of LGV may be difficult, but LGV should be swab can be done. Serology assays are sensitive but
suspected in any patient with infected sexual contacts, nonspecific due to cross reactivity with other
genital ulcer, perianal fistula, or bubo. The accuracy chlamydial infec- tions. In addition, they do not
of clinical diagnosis has been reported to be as low differentiate current from prior infection. Frei test, the
41
as 20%. Therefore, laboratory tests are important to earliest diagnostic modality to identify LGV, consists
establish the diagnosis and are usually divided into of an intradermal skin test assessing delayed
two broad categories: (1) nonspecific tests that do not hypersensitivity to chla- mydial antigens. It is no
distinguish between LGV and (2) non-LGV serovars, longer used because of its low sensitivity and
and specific LGV tests. In practice, a positive test on limited specificity due to cross reaction with C.
17
LN aspirate is considered diagnostic of LGV, in con- trachomatis D-K. Finally, other non specific
trast to a positive test on primary genital lesion where laboratory findings include mild leukocytosis, false-
further specific testing is required to rule out common positive VDRL, cryoprecipitates, rheumatoid fac- tor,
and high serum levels of immunoglobulin A and
49
immunoglobulin G.
DIAGNOSTIC PROCEDURES
Bubo aspiration to obtain material for culture and
direct microscopy should be performed through a lat-
eral approach, and may require injection of 2–5 mL of
sterile saline before the aspiration due to the paucity
of milky fluid.48 Proctoscopic examination reveals, in
chlamydial urogenital infections. the setting of the ArS, multiple discrete and irregular
SPECIFIC TESTS FOR superficial ulcerations and friable granulation tissue,
usually confined to the distal 10 cm of the anorectal
LYMPHOGRANULOMA VENEREUM canal.
50,51
(syphilis, chancroid, herpes simplex virus) Recently several case reports have described an
incarcerated inguinal hernia associa- tion between LGV and sexually acquired
Reactive inguinal lymphadenitis to a lower reactive arthri- tis (SARA) in HLA-B27 positive
54,55
individuals.
extremity focus of infection
Bubonic plague (in endemic areas)
Acquired immunodeficiency syndrome PROGNOSIS AND CLINICAL
Kaposi sarcoma
COURSE Ch
Tularemia apt
Mycobacterial infections er
Antibiotic treatment, if given early, is curative, with
Acute anorectal syndrome the acute ArS responding more dramatically than the
20
inflammatory bowel disease acute GS. 3
oropharyngeal lymphogranuloma venereum ::
Ly
Lymphoma
infectious mononucleosis
TREATMENT m
ph
Cat-scratch disease Oral doxycycline, 100 mg twice daily for 3 weeks, is og
Tertiary stage the treatment of choice. When contraindicated, oral ra
Malignancy eryth- romycin base, at a dose of 500 mg four times a nu
Filariasis and other parasitic infections day for lo
Pseudoelephantiasis (no lymphadenitis) of 3 weeks, may be given. Treatment with azithromycin m
56
(1 g once weekly for 3 weeks or in a single dose) is a
tuberculosis and granuloma inguinale likely curative but still lacks data regarding its efficacy
Deep fungal infection and safety in pregnancy. It should be noted that the
Ve
hidradenitis suppurativa duration of treatment needed to eradicate C. trachoma- ne
Trauma tis is longer for the LGV serovars compared with the re
other less invasive serovars of C. trachomatis. There- u
fore, when in doubt about the Chlamydia serovar, a
3-week course of antibiotics is advised. Therapy may
be prolonged in HIV-positive patients and, in general,
containing little or no pus are, however, more likely to should not be stopped until the complete resolution of
44
be caused by LGV. Suspecting LGV proctitis in HIV- all signs and symptoms (Box 203-2).
positive MSM who present with signs and symptoms Surgery is often required in late stages and includes
of Crohn’s disease is important, even in the absence lateral aspiration of buboes through intact skin (direct
of LGV pathognomonic findings. Both conditions incision has a high risk of fistula formation), rectal
have similar proctoscopic findings; however, Crohn’s stricture dilatation, abscess drainage, rectovaginal
dis- ease is more proximally localized. fistula repair, genital reconstruction, and colostomy.
Avoidance of sexual activity until complete resolution
57
of signs and symptoms is important.
PREVENTION
LGV seems to be a rapidly spreading universal prob-
lem. Effective control should include periodic evalua-
tion of high-risk individuals, reinforcement of health
intracellular Donovan bodies on histology. There are new endemic areas of donovanosis, mainly
South and Central America, India, and Papua New
12
Guinea, but the overall incidence of GI seems to be
1
decreasing, especially in Papua New Guinea. The dis-
EPIDEMIOLOGY AND MODE ease has nearly been eradicated from Australia, with
14
only five cases reported in 2004, and is rare in North
OF TRANSMISSION America and Europe.
15–17